CHARLESTON, S.C., April 28, 2011 (GLOBE NEWSWIRE) -- Revolutions Medical Corp. ("Revolutions Medical" or the "Company") (OTCQB:RMCP) will be an exhibitor at the 7th annual Homeland Security Innovation Conference on May 4th-May 5th, 2011 at the Charleston Area Convention Center.
The conference is expected to attract in excess of 500 attendees from national, state and local firms, government agencies and military commands. It will provide a great opportunity for organizations of all sizes to showcase their technology and innovative solutions to decision makers responsible for defending the homeland.
For more information on the Homeland Security Innovation Conference please visit their website, .
About Revolutions Medical Corporation
Revolutions Medical is a safety medical device and software application company. Its products include the RevVac™ Safety Syringe (FDA cleared), safety blood drawing device, the RevColor™, RevDisplay™ and Rev3D™ software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS). The Company also has an exclusive license to a Breast Biopsy System (BBS), preliminary called RevTrack (FDA cleared).
For additional information, please visit Revolutions Medical corporate website:
To be added to the Revolutions Medical investor email list, please email: firstname.lastname@example.org with RMCP in the subject line.
Become a RevMed fan and follow the Company on Facebook – visit:
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
CONTACT: Revolutions Medical Corporation Investor and Corporate Relations Gregory S. Lowe Acorn Management Partners President / Partner 678-368-4013